Institute of Virology, Philipps University, Marburg, Germany.
Thromb Haemost. 2009 Dec;102(6):1014-23. doi: 10.1160/TH09-05-0310.
Nipah virus (NiV) is a highly pathogenic paramyxovirus that was first isolated in 1999 during an outbreak in Malaysia. In contrast to other paramyxoviruses NiV infects many mammalian species. Because of its zoonotic potential, the high pathogenicity and the lack of therapeutic treatment, NiV was classified as a biosafety level 4 pathogen. In humans NiV causes a severe acute encephalitis whereas in some animal hosts respiratory symptoms are predominantly observed. Despite the differences in the clinical outcome, microvascular endothelial cell damage predominantly underlies the pathological changes in NiV infections in all susceptible host species. NiV generally induces a pronounced vasculitis which is primarily characterised by endothelial cell necrosis and inflammatory cell infiltration. For future developments of specific antiviral therapies or vaccines, a detailed understanding of the molecular basis of NiV pathogenesis is required. This article reviews the current knowledge about natural and experimental infections in different mammals, focusing on the main organ and cell tropism in vivo, and summarises some recent studies in cell culture on the role of ephrin-B2 and -B3 receptors in NiV infection of endothelial cells.
尼帕病毒(NiV)是一种高致病性副粘病毒,于 1999 年在马来西亚的一次疫情中首次被分离出来。与其他副粘病毒不同,NiV 感染许多哺乳动物物种。由于其具有人畜共患的潜力、高致病性和缺乏治疗方法,NiV 被归类为生物安全 4 级病原体。在人类中,NiV 引起严重的急性脑炎,而在一些动物宿主中,主要观察到呼吸道症状。尽管临床结果存在差异,但在所有易感宿主物种的 NiV 感染中,微血管内皮细胞损伤主要是病理变化的基础。NiV 通常会引起明显的血管炎,其主要特征是内皮细胞坏死和炎症细胞浸润。为了未来开发特定的抗病毒疗法或疫苗,需要详细了解 NiV 发病机制的分子基础。本文综述了不同哺乳动物中天然和实验感染的最新知识,重点介绍了体内主要的器官和细胞嗜性,并总结了一些最近在细胞培养中关于 Ephrin-B2 和 Ephrin-B3 受体在 NiV 感染内皮细胞中的作用的研究。